Skip to main content
main-content

COVID-19


Browse the latest news, expert commentary, and educational content on COVID-19.


Highlights

23-07-2021 | COVID-19 | News

Trial results do not support canakinumab for COVID-19

Treatment with the IL-1β inhibitor canakinumab does not improve the likelihood of survival without invasive mechanical ventilation among hospitalized patients with severe COVID-19 and systemic hyperinflammation, suggest findings from the CAN-COVID trial.

13-07-2021 | COVID-19 | News

Methotrexate dulls humoral but not cellular response to COVID-19 vaccine

UK research suggests there is a disparity between humoral and cellular immune responses to the first dose of the Pfizer–BioNTech COVID-19 vaccine in people on methotrexate monotherapy for psoriasis.

25-06-2021 | COVID-19 | News

Study supports importance of second COVID-19 vaccine dose in DMARD-treated RA patients

Rheumatoid arthritis patients are more likely than healthy controls to require both doses of vaccines against SARS-CoV-2 in order to mount an adequate immune response, researchers report.

COVID-19 vaccination in patients with rheumatic diseases

Get answers to key questions with recommendations from professional organizations

COVID-19 in rheumatic disease patients

Repurposing rheumatology drugs for COVID-19

Experts discuss the rationale, data on different agents, and the potential impact on rheumatology practice.

Repurposing rheumatology drugs for COVID-19

Telemedicine in rheumatology

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

COVID-19 guidance for rheumatologists

Keep up with podcasts on this topic, available on

Stay informed with Medicine Matters

Get the latest developments in rheumatology delivered straight to your inbox

Image Credits